뉴스벤징가
GSK Races To Protect Profits Before Its HIV Blockbuster Faces Generic Rivals
· 발표
기사 요약
GSK beats Q2 revenue and earnings estimates, launches a $2.52B cost-savings program, and updates its 2026 guidance.
기사 원문에서 발췌했어요.GSK beats Q2 revenue and earnings estimates, launches a $2.52B cost-savings program, and updates its 2026 guidance.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…